GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSeed Inc (TSE:7776) » Definitions » Institutional Ownership

CellSeed (TSE:7776) Institutional Ownership : 0.57% (As of Mar. 04, 2025)


View and export this data going back to 2010. Start your Free Trial

What is CellSeed Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, CellSeed's institutional ownership is 0.57%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, CellSeed's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, CellSeed's Float Percentage Of Total Shares Outstanding is 0.00%.


CellSeed Institutional Ownership Historical Data

The historical data trend for CellSeed's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSeed Institutional Ownership Chart

CellSeed Historical Data

The historical data trend for CellSeed can be seen below:

2016-09-30 2016-10-31 2016-11-30 2018-02-28 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31
Institutional Ownership 0.02 0.02 0.02 0.15 0.48 0.46 0.57 0.57 0.57 0.57

CellSeed Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


CellSeed Business Description

Traded in Other Exchanges
N/A
Address
Katsura-Bldg, 4F, 3-61, Haramachi, Shinjuku-ku, Tokyo, 162-0053, JPN
CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet regenerative medicines, such as epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis.

CellSeed Headlines

No Headlines